JPRN-UMIN000007070
Completed
未知
The beneficial effect and safety Eldecalcitol with combined peginterferon alpha-2a plus ribavirin for chronic hepatitis C patients with osteoporosis - CHALLENGE A plus trial
Department of Hepatology, Osaka City University Graduate School of Medicine0 sites50 target enrollmentMarch 31, 2015
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Hepatology, Osaka City University Graduate School of Medicine
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The following patients were excluded 1\. women of childbearing potential and pregnancy, lactating women 2\. allergic to ribavirin or other nucleoside analoges 3\. an uncontrollable heart trouble( myocardial infarction, heart failure, or arrhythmia) 4\. hemoglobibopathy ( thalassemia, sickle cell disease) 5\. severe renal disease or Ccr\<50mL/min 6\. severe depression or psychosomatic disorders 7\. severe liver diseases 8\. autoimmune hepatitis or HBV 9\. drug allegy against interferon 10\. allergic to vaccine or biological preperations 11\. concomitant herbal medication of Sho\-saiko\-to 13\. history of interstitial pneumonia 14\. patients who take active vitamin D3 other than Eldecalcitol 15\. other conditions considerd inappropriate by attending physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
The safety and efficacy of etelcalcetide for the treatment of secondary hyperparathyroidism compared with cinacalcetPatients on maintenance hemodialysis treated with cinacalcet for secondary hyperparathyroidismJPRN-UMIN000028041Matsunami general hospital20
Recruiting
Not Applicable
The safety and efficacy of etelcalcetide for the treatment of secondary hyperparathyroidism compared with cinacalcetPatients on maintenance hemodialysis treated with cinacalcet for secondary hyperparathyroidismJPRN-UMIN000027344Matsunami general hospital10
Not yet recruiting
Not Applicable
Effect of Vitamin D and turmeric in lymphoma patients.CTRI/2020/06/025818JIPMER Intramural fund
Active, not recruiting
Phase 1
Efficacy Study of Inecalcitol in Combination with Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard ChemotherapyAcute Myeloid LeukemiaMedDRA version: 20.0Level: LLTClassification code 10000886Term: Acute myeloid leukemiaSystem Organ Class: 100000012984Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2015-002983-18-BEHybrigenics S.A.110
Active, not recruiting
Phase 1
Efficacy Study of Inecalcitol in Combination with Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard ChemotherapyEUCTR2015-002983-18-ESHybrigenics S.A.110